MedCap AB (publ)

Stockholm Stock Exchange MCAP.ST

MedCap AB (publ) Operating Income Margin for the year ending December 31, 2023: 14.33%

MedCap AB (publ) Operating Income Margin is 14.33% for the year ending December 31, 2023, a -6.80% change year over year. Operating Income Ratio is the proportion of a company's operating income to its net sales, measuring the efficiency of its core business operations in generating profits.

MedCap AB (publ) Operating Income Margin for the year ending December 31, 2022 was 15.38%, a 10.94% change year over year.
MedCap AB (publ) Operating Income Margin for the year ending December 31, 2021 was 13.86%, a 27.15% change year over year.
MedCap AB (publ) Operating Income Margin for the year ending December 31, 2020 was 10.90%, a -0.81% change year over year.
MedCap AB (publ) Operating Income Margin for the year ending December 31, 2019 was 10.99%, a 1,955.10% change year over year.

Key data

Date	Operating Income Margin	EBT Margin	Net Income Margin	EBITDA Margin

Stockholm Stock Exchange: MCAP.ST

MedCap AB (publ)

CEO	Mr. Anders Dahlberg
IPO Date	Nov. 9, 2007
Location	Sweden
Headquarters	Sundbybergsvägen 1
Employees	534
Sector	Finance
Industries Private Equity Hedge Funds Investment Banking & Asset Management Venture Capital

Description

MedCap AB (publ) is a private equity firm specializing in investments in secondary direct, later stage, industry consolidation, growth capital, middle market, mature, turnarounds, buyout. It prefers to invest in healthcare equipment and services, biotechnology, life sciences, and pharmaceuticals companies. The firm prefers to invest in small to medium size companies that are not listed on the stock exchange and are based in Northern Europe. It typically invests between SEK25 million ($2.75 million) to SEK150 million ($16.51 million) with enterprise value and sales revenue between SEK50 million ($5.90 million) to SEK200 million ($23.06 million) and EBITDA between SEK1 million ($0.11 million) to SEK50 million ($5.50 million). The firm seeks to acquire stakes between 20% and 50% in its portfolio companies. It uses its capital and loans and makes balance sheet investments. MedCap AB (publ) was founded in 2001 and is based in Stockholm, Sweden.

Key trends

Past 5 years